title: Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo.
abstract: The effects of VIP (300 pmol/kg), injected via the portal vein, on the glycogen content of the liver and on glycemia, were studied in the rat in vivo. VIP enhanced glycogenolysis and caused hyperglycemia in a time-dependent manner.
authors.affiliation: Department of Medical Biochemistry and Molecular Biology, Medical School, University of Sevilla, Spain.
authors.forename: V
authors.initials: V
authors.lastname: Sánchez
authors.forename: R
authors.initials: R
authors.lastname: Goberna
authors.forename: J R
authors.initials: JR
authors.lastname: Calvo
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D005934:Glucagon / Q000097:blood; D006003:Glycogen / Q000378:metabolism*; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D011169:Portal Vein; D051381:Rats; D011919:Rats, Inbred Strains; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D014660:Vasoactive Intestinal Peptide; D006003:Glycogen; D005934:Glucagon